Open Chemistry (Jun 2020)

Chirality of β2-agonists. An overview of pharmacological activity, stereoselective analysis, and synthesis

  • Ružena Čižmáriková,
  • Jindra Valentová,
  • Renáta Horáková

DOI
https://doi.org/10.1515/chem-2020-0056
Journal volume & issue
Vol. 18, no. 1
pp. 628 – 647

Abstract

Read online

β2-Agonists (β2-adrenergic agonists, bronchodilatants, and sympathomimetic drugs) are a group of drugs that are mainly used in asthma and obstructive pulmonary diseases. In practice, the substances used to contain one or more stereogenic centers in their structure and their enantiomers exhibit different pharmacological properties. In terms of bronchodilatory activity, (R)-enantiomers showed higher activity. The investigation of stereoselectivity in action and disposition of chiral drugs together with the preparation of pure enantiomer drugs calls for efficient stereoselective analytical methods. The overview focuses on the stereoselectivity in pharmacodynamics and pharmacokinetics of β2-agonists and summarizes the stereoselective analytical methods for the enantioseparation of racemic beta-agonists (HPLC, LC-MS, GC, TLC, CE). Some methods of the stereoselective synthesis for β2-agonists preparation are also presented.

Keywords